Single Molecule Biophysics, Institute of Physical and Theoretical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 7, 60438 Frankfurt, Germany.
SomaLogic, Inc., Boulder, CO 80301, USA.
Int J Mol Sci. 2020 Apr 17;21(8):2803. doi: 10.3390/ijms21082803.
Receptor tyrosine kinases (RTKs) orchestrate cell motility and differentiation. Deregulated RTKs may promote cancer and are prime targets for specific inhibitors. Increasing evidence indicates that resistance to inhibitor treatment involves receptor cross-interactions circumventing inhibition of one RTK by activating alternative signaling pathways. Here, we used single-molecule super-resolution microscopy to simultaneously visualize single MET and epidermal growth factor receptor (EGFR) clusters in two cancer cell lines, HeLa and BT-20, in fixed and living cells. We found heteromeric receptor clusters of EGFR and MET in both cell types, promoted by ligand activation. Single-protein tracking experiments in living cells revealed that both MET and EGFR respond to their cognate as well as non-cognate ligands by slower diffusion. In summary, for the first time, we present static as well as dynamic evidence of the presence of heteromeric clusters of MET and EGFR on the cell membrane that correlates with the relative surface expression levels of the two receptors.
受体酪氨酸激酶 (RTKs) 协调细胞运动和分化。失调的 RTKs 可能促进癌症的发生,是特定抑制剂的主要靶点。越来越多的证据表明,对抑制剂治疗的耐药性涉及受体交叉相互作用,通过激活替代信号通路来绕过对一种 RTK 的抑制。在这里,我们使用单分子超分辨率显微镜,在固定和活细胞中同时可视化两种癌细胞系 HeLa 和 BT-20 中单个 MET 和表皮生长因子受体 (EGFR) 簇。我们发现,配体激活促进了这两种细胞类型中 EGFR 和 MET 的异源受体簇的形成。活细胞中的单个蛋白追踪实验表明,MET 和 EGFR 都通过较慢的扩散来响应其同源和非同源配体。总之,这是首次在细胞膜上存在 MET 和 EGFR 的异源簇的静态和动态证据,这与两种受体的相对表面表达水平相关。